TGOD gave a date to spin-off shares of SpinCo, its acquisition vehicle. US shareholders wont receive warrants, which at least one analyst I follow says means the investments are likely to be in the United States.
Hexo raising some cash, but apparently got favorable terms. With the uplisting, I'm happy to see it holding stable.
Quote:
I remember a co-worker recommended me to get marijuana stocks in 2017. I had another co-worker recently tell me they were invested in a marijuana stock. I think ordinary people think because marijuana is becoming legal everywhere that they are insightful for thinking of investing in marijuana stock without justifying the price.
I'm not an expert with this kind of thing, but it seems like it could be overhyped. I looked at a balance sheet of one of these marijuana stocks recommended to me and it was in mountains and mountains of debt. Buyer beware.
I think the key is buying well-run companies that are not already too expensive. ... maybe that's no-brainer, but yeah you're right, just having marijuana in your business plan doesn't guarantee anything.
That said, there will be well-run companies making money. The demand for marijuana is there, someone will profit.
One thing I like about TGOD is that it seems to be targeting a fairly specific set of customers/attributes: Medical, Online, Organic. And when their buildout is complete, assuming (??!) it goes as planned, they will be one of the larger producers.
I liked the company at much higher prices, before the crappy October-November selloffs, so getting in below $2.50 seems great to me.